Investing.com - Aspen Aerogels Inc (NYSE: ASPN) reported second quarter EPS of $-0.22, $0.15 better than the analyst estimate of $-0.37. Revenue for the quarter came in at $48.2M versus the consensus estimate of $48.81M.
Guidance
Aspen Aerogels Inc sees FY 2023 revenue of $200.00M-$250.00M versus the analyst consensus of $225.70M.
Aspen Aerogels Inc's stock price closed at $7.43. It is up 0.00% in the last 3 months and down -49.59% in the last 12 months.
Aspen Aerogels Inc saw 2 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Aspen Aerogels Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Aspen Aerogels Inc's Financial Health score is "fair performance".
Check out Aspen Aerogels Inc's recent earnings performance, and Aspen Aerogels Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar